Rabies Challenge Fund
The Rabies Challenge Fund is pleased to announce that the canine rabies
challenge studies have begun!!! Permission is granted to post and cross-post
the text of our press release below.
Regards, Kris L. Christine
The Rabies Challenge Fund
CANINE RABIES CHALLENGE STUDIES BEGIN !
One of the most important vaccine research studies in veterinary medicine is
underway at the University of Wisconsin School of Veterinary Medicine in
Madison. Dr. Ronald Schultz, a leading authority on veterinary vaccines and
Chair of the Department of Pathobiological Sciences, has begun concurrent 5 and
7 year challenge studies to determine the long-term duration of immunity of
the canine rabies vaccine, with the goal of extending the state-mandated
interval for boosters.
These will be the first long-term challenge studies on the
canine rabies vaccine to be published in the United States.
Dr. Schultz comments that: "We are all very excited to start this study that
will hopefully demonstrate that rabies vaccines can provide a minimum of 7
years of immunity."
This research is being financed by The Rabies Challenge Fund, a charitable
trust founded by pet vaccine disclosure advocate Kris L. Christine of Maine,
who serves as Co-Trustee with world-renowned veterinary research scientist
and practicing clinician, Dr. W. Jean Dodds of Hemopet in California. The
Rabies Challenge Fund recently met its goal of $177,000 to fund the studies’
first year budget with contributions from dog owners, canine groups, trainers,
veterinarians, and small businesses. Annual budget goals of $150,000 for the
studies must be met in the future.
Dr. Jean Dodds, DVM states: "This is the first time in my 43 years of
involvement in veterinary issues that what started as a grass-roots effort to
change an outmoded regulation affecting animals will be addressed scientifically
by an acknowledged expert to benefit all canines in the future."
Scientific data published in 1992 by Michel Aubert and his research team
demonstrated that dogs were immune to a rabies challenge 5 years after
vaccination, while Dr. Schultz’s serological studies documented antibody titer counts
at levels known to confer immunity to rabies 7 years post-vaccination. This
data strongly suggests that state laws requiring annual or triennial rabies
boosters for dogs are redundant. Because the rabies vaccine is the most
potent of the veterinary vaccines and associated with significant adverse
reactions, it should not be given more often than is necessary to maintain
immunity. Adverse reactions such autoimmune diseases affecting the thyroid, joints,
blood, eyes, skin, kidney, liver, bowel and central nervous system;
anaphylactic shock; aggression; seizures; epilepsy; and fibrosarcomas at injection
sites are linked to rabies vaccinations.
Study co-trustee Kris Christine adds: “Because the USDA does not require
vaccine manufacturers to provide long-term duration of immunity studies
documenting maximum effectiveness when licensing their products, concerned dog
owners have contributed the money to fund this research themselves. We want to
ensure that rabies immunization laws are based upon independent, long-term
More information and regular updates on The Rabies Challenge Fund and the
concurrent 5 and 7 year challenge studies it is financing can be found at the
fund’s website designed by volunteer Andrea Brin at:
_www.RabiesChallengeFund.org_ (http://www.rabieschallengefund.org/) ."
"Run with the dogs, tonight...in Suburbia"-Pet Shop Boys